StockData
Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc. (BOLT) income statement

BOLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/307% below fair value
$4.91−0.15 (-2.96%)

Close on Nov 20, 2026Market cap $9.46MP/E –Yield –

See a number that looks wrong?